ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly

Theodoros Karampitsakos, Phuong Phuong Diep, Daan W. Loth, Iftikhar Nadeem, Elene Khurtsidze, Marlies S. Wijsenbeek, Wim A. Wuyts, Elena Bargagli, Antoine Froidure, Paolo Spagnolo, Marcel Veltkamp, Maria Molina-Molina, Cormac McCarthy, Katerina M. Antoniou, Michael Kreuter, Catharina C. Moor*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
15 Downloads (Pure)


This article contains a selection of scientific highlights in the field of interstitial lung diseases (ILDs) presented at the hybrid European Respiratory Society International Congress 2022. Early Career Members of Assembly 12 summarise recent advances in translational and clinical research in idiopathic interstitial pneumonias, ILDs of known origin, sarcoidosis and other granulomatous diseases, and rare ILDs. Many studies focused on evaluation of diagnostic and prognostic (bio)markers, and novel pharmacological and nonpharmacological treatment options for different ILDs. In addition, new insights in clinical, physiological and radiological features of various rare ILDs were presented.

Original languageEnglish
Article number00584-2022
JournalERJ Open Research
Issue number2
Publication statusPublished - 1 Mar 2023

Bibliographical note

Publisher Copyright: © The authors 2023.


Dive into the research topics of 'ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly'. Together they form a unique fingerprint.

Cite this